Pricing Log in Create free account
Saturday 17 October 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.

85.81 2.05 −2.33%
Market cap
$15.0B
P/E
10.4×
Fwd P/E
39.0×
Dividend yield
—
F-score
5/9
Altman Z
2.22
Beneish M
−2.07
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Solventum Corporation (SOLV) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Solventum Corporation (SOLV) trades at a EV/Sales of 2.4×. Over the past ten years it has ranged from 1.4× (March 2024) to 2.6× (February 2025); the current reading is higher than 64% of that period. That is below the Medical Instruments & Supplies industry median of 2.9× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× (4.23%)
FY2024 2.3× 36.26%
FY2023 1.7× 0.00%
FY2022 1.7× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 2.2× 12.43%
Mar 2026 1.9× (10.13%)
Dec 2025 2.2× 11.65%
Sep 2025 1.9× (21.02%)
10 more quarters

Against its own ten years

Low 1.4× High 2.6×
Ten-year median 2.3×
Current reading's percentile 64

EV/Sales against peers

Company EV/Sales
BAX Baxter International Inc. compare 1.8×
AVTR Avantor, Inc. compare 2.2×
ALGN Align Technology, Inc. compare 2.3×
ATR AptarGroup, Inc. compare 2.3×
SOLV Solventum Corporation 2.4×
COO The Cooper Companies, Inc. compare 3.2×
ALC Alcon compare 3.3×
WST West Pharmaceutical Services, Inc. compare 8.1×
RGEN Repligen Corporation compare 12.3×
Medical Instruments & Supplies industry median 2.9×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SOLV